Western blotting analysis (Fig. 5c) showed source membrane markers were well retained in the CCM vehicles, including two plasma membrane-specific markers (cadherins and Na+ /K+ -ATPase) and a widely reported tumor-associated transmembrane protein (glycoprotein 100 or gp100). The gene discussed is PMEL; the disease is neoplasm.